Overview

Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke

Status:
Not yet recruiting

Trial end date:
2024-12-31

Target enrollment:

Participant gender:

Summary

The primary objective of this study was to evaluate the efficacy and safety of initiation of edaravone dextivel therapy compared with placebo in patients with acute ischaemic stroke (early and late) and to explore the optimal time window for "brain cell protective therapy" of edaravone dexborneol.

Phase:

Phase 3

Details

Lead Sponsor:

Xiangya Hospital of Central South University

Collaborator:

Jiangsu Simcere Pharmaceutical Co., Ltd.

Treatments:

Edaravone